Methadone

FDA's Strategies for Managing Patients Taking CNS Depressants and Opioids

FDA's Strategies for Managing Patients Taking CNS Depressants and Opioids

By

The FDA has recently issued a report advising against the use of buprenorphine and methadone medications in patients taking benzodiazepines and/or other central nervous system depressants.

WHO Updates, Revises Essential Medicines List

WHO Updates, Revises Essential Medicines List

By

WHO has updated its Essential Medicines List to include new recommendations on which antibiotics to use for common infections and serious conditions.

Ketamine for Refractory Neuropathic Pain

Ketamine for Refractory Neuropathic Pain

By

A ketamine regimen is superior to methadone, or ketamine combined with methadone, in alleviating neuropathic pain and associated sensory changes.

Methadone: Best Practices for Weaning Pediatric Patients

Methadone: Best Practices for Weaning Pediatric Patients

By

Practices pertaining to the use of methadone to facilitate opioid weaning in pediatric patients are widely heterogeneous.

Identifying Patients With Higher Methadone Dose Requirements

Identifying Patients With Higher Methadone Dose Requirements

By

Polymorphism at the level of drug receptors, transporters, or other proteins involved in drug metabolism or action may have an impact on the effect of a drug.

New Prescribing Information Released for Hundreds of FDA-Approved Opioids

New Prescribing Information Released for Hundreds of FDA-Approved Opioids

Throughout 2016, the FDA has announced requirements for manufacturers to create new product labeling information for a variety of opioid medications.

Sign Up for Free e-Newsletters